Isabelle Cadron

2.0k total citations
43 papers, 1.4k citations indexed

About

Isabelle Cadron is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Surgery. According to data from OpenAlex, Isabelle Cadron has authored 43 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Reproductive Medicine, 22 papers in Obstetrics and Gynecology and 15 papers in Surgery. Recurrent topics in Isabelle Cadron's work include Ovarian cancer diagnosis and treatment (26 papers), Endometrial and Cervical Cancer Treatments (14 papers) and Intraperitoneal and Appendiceal Malignancies (10 papers). Isabelle Cadron is often cited by papers focused on Ovarian cancer diagnosis and treatment (26 papers), Endometrial and Cervical Cancer Treatments (14 papers) and Intraperitoneal and Appendiceal Malignancies (10 papers). Isabelle Cadron collaborates with scholars based in Belgium, Germany and Austria. Isabelle Cadron's co-authors include Ignace Vergote, Frédéric Amant, Toon Van Gorp, Karin Leunen, Patrick Neven, D. Timmerman, Anneleen Daemen, Evelyn Despierre, Robert Zeillinger and Bart De Moor and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

Isabelle Cadron

41 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Isabelle Cadron Belgium 20 929 648 418 272 229 43 1.4k
Lotte Nedergaard Denmark 21 916 1.0× 681 1.1× 343 0.8× 200 0.7× 220 1.0× 41 1.4k
Toshiko Jobo Japan 20 1.1k 1.1× 717 1.1× 410 1.0× 294 1.1× 636 2.8× 70 1.8k
Gianni Amunni Italy 20 449 0.5× 526 0.8× 188 0.4× 261 1.0× 358 1.6× 55 1.2k
J. J. Kavanagh United States 17 545 0.6× 232 0.4× 303 0.7× 308 1.1× 396 1.7× 50 1.2k
Vanda Salutari Italy 23 722 0.8× 412 0.6× 291 0.7× 333 1.2× 555 2.4× 110 1.5k
Hidekatsu Nakai Japan 21 667 0.7× 418 0.6× 191 0.5× 323 1.2× 445 1.9× 75 1.3k
E. A. Eisenhauer Canada 16 504 0.5× 241 0.4× 313 0.7× 357 1.3× 404 1.8× 31 1.2k
Lisa Barroilhet United States 21 393 0.4× 357 0.6× 162 0.4× 356 1.3× 216 0.9× 62 1.1k
F. Raja United Kingdom 6 781 0.8× 207 0.3× 230 0.6× 290 1.1× 497 2.2× 12 1.2k
Jamie Lesnock United States 16 317 0.3× 382 0.6× 292 0.7× 186 0.7× 332 1.4× 52 1.2k

Countries citing papers authored by Isabelle Cadron

Since Specialization
Citations

This map shows the geographic impact of Isabelle Cadron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabelle Cadron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabelle Cadron more than expected).

Fields of papers citing papers by Isabelle Cadron

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabelle Cadron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabelle Cadron. The network helps show where Isabelle Cadron may publish in the future.

Co-authorship network of co-authors of Isabelle Cadron

This figure shows the co-authorship network connecting the top 25 collaborators of Isabelle Cadron. A scholar is included among the top collaborators of Isabelle Cadron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabelle Cadron. Isabelle Cadron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Valabrega, Giorgio, Ignace Vergote, Debra L. Richardson, et al.. (2025). Longer-Term Safety And Efficacy Of Selinexor Maintenance Therapy For Patients With TP53wt Advanced Or Recurrent Endometrial Cancer: Follow-Up Subgroup Analysis Of The ENGOT-EN5/GOG-3055/SIENDO Study. International Journal of Gynecological Cancer. 35(2). 100081–100081. 1 indexed citations
2.
3.
Pils, Dietmar, Gudrun Hager, Dan Cacsire Castillo‐Tong, et al.. (2012). Validating the impact of a molecular subtype in ovarian cancer on outcomes: A study of theOVCADConsortium. Cancer Science. 103(7). 1334–1341. 51 indexed citations
4.
Zaal, Afra, Wouter J. Peyrot, P.M.J.J. Berns, et al.. (2012). Genomic aberrations relate early and advanced stage ovarian cancer. Cellular Oncology. 35(3). 181–188. 6 indexed citations
5.
Cadron, Isabelle, et al.. (2012). Evaluation of paclitaxel/carboplatin in a dose dense or weekly regimen in 66 patients with recurrent or primary metastatic cervical cancer. European Journal of Cancer. 48(9). 1332–1340. 21 indexed citations
6.
Gorp, Toon Van, Isabelle Cadron, Anneleen Daemen, et al.. (2012). Proteomic biomarkers predicting lymph node involvement in serum of cervical cancer patients. Limitations of SELDI-TOF MS. Proteome Science. 10(1). 41–41. 10 indexed citations
7.
Polterauer, Stephan, Ignace Vergote, Nicole Concin, et al.. (2012). Prognostic Value of Residual Tumor Size in Patients With Epithelial Ovarian Cancer FIGO Stages IIA-IV. International Journal of Gynecological Cancer. 22(3). 380–385. 91 indexed citations
8.
Hofstetter, Gerda, Astrid Berger, E. Schuster, et al.. (2011). Δ133p53 is an independent prognostic marker in p53 mutant advanced serous ovarian cancer. British Journal of Cancer. 105(10). 1593–1599. 37 indexed citations
9.
Gorp, Toon Van, Isabelle Cadron, Evelyn Despierre, et al.. (2011). HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm. British Journal of Cancer. 104(5). 863–870. 269 indexed citations
10.
Cadron, Isabelle, Toon Van Gorp, Attila Mihalyi, et al.. (2010). The impact of enzastaurin (LY317615.HCl) on CA125 biosynthesis and shedding in ovarian cancer cells. Gynecologic Oncology. 118(1). 64–68. 5 indexed citations
11.
Gorp, Toon Van, Isabelle Cadron, & Ignace Vergote. (2010). The utility of proteomics in gynecologic cancers. Current Opinion in Obstetrics & Gynecology. 23(1). 3–7. 18 indexed citations
12.
Braicu, Elena Ioana, Robert Zeillinger, Ignace Vergote, et al.. (2010). Use of HE4 expression in plasma to predict operative outcome in patients with ovarian cancer (OC).. Journal of Clinical Oncology. 28(15_suppl). 5022–5022. 1 indexed citations
13.
Cadron, Isabelle, Toon Van Gorp, D. Timmerman, et al.. (2009). Application of proteomics in ovarian cancer: Which sample should be used?. Gynecologic Oncology. 115(3). 497–503. 14 indexed citations
14.
Vergote, Ignace, Toon Van Gorp, Karin Leunen, et al.. (2008). Robotic retroperitoneal lower para‐aortic lymphadenectomy in cervical carcinoma: First report on the technique used in 5 patients. Acta Obstetricia Et Gynecologica Scandinavica. 87(7). 783–787. 46 indexed citations
15.
Cadron, Isabelle, Karin Leunen, Frédéric Amant, et al.. (2007). The “Leuven” dose-dense paclitaxel/carboplatin regimen in patients with recurrent ovarian cancer. Gynecologic Oncology. 106(2). 354–361. 32 indexed citations
16.
Amant, Frédéric, Isabelle Cadron, Luca Fuso, et al.. (2005). Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer. Gynecologic Oncology. 98(2). 274–280. 100 indexed citations
17.
Ombelet, Willem, Isabelle Cadron, Jan Gerris, et al.. (2005). Obstetric and perinatal outcome of 1655 ICSI and 3974 IVF singleton and 1102 ICSI and 2901 IVF twin births: a comparative analysis. Reproductive BioMedicine Online. 11(1). 76–85. 45 indexed citations
18.
Amant, Frédéric, Philippe Moerman, Isabelle Cadron, et al.. (2003). The diagnostic problem of endometrial stromal sarcoma: report on six cases. Gynecologic Oncology. 90(1). 37–43. 47 indexed citations
19.
Amant, Frédéric, Philippe Moerman, Isabelle Cadron, et al.. (2003). Endometrial stromal sarcoma with a sole t(X;17) chromosome change: report of a case and review of the literature. Gynecologic Oncology. 88(3). 459–462. 23 indexed citations
20.
Amant, Frédéric, Philippe Moerman, Isabelle Cadron, et al.. (2002). The diagnostic problem of endometrial stromal sarcoma. International Journal of Gynecological Cancer. 12(5). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lotte Nedergaard Breakdown of academic impact, for papers by Toshiko Jobo Breakdown of academic impact, for papers by Gianni Amunni Breakdown of academic impact, for papers by J. J. Kavanagh Breakdown of academic impact, for papers by Vanda Salutari Breakdown of academic impact, for papers by Hidekatsu Nakai Breakdown of academic impact, for papers by E. A. Eisenhauer Breakdown of academic impact, for papers by Lisa Barroilhet Breakdown of academic impact, for papers by F. Raja Breakdown of academic impact, for papers by Jamie Lesnock
Rankless by CCL
2026